IL53323A - 1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them - Google Patents

1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53323A
IL53323A IL53323A IL5332377A IL53323A IL 53323 A IL53323 A IL 53323A IL 53323 A IL53323 A IL 53323A IL 5332377 A IL5332377 A IL 5332377A IL 53323 A IL53323 A IL 53323A
Authority
IL
Israel
Prior art keywords
phenoxymethylpiperidino
propanes
benzotriazolyl
indazolyl
benzimidazolyl
Prior art date
Application number
IL53323A
Other languages
English (en)
Other versions
IL53323A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL53323A0 publication Critical patent/IL53323A0/xx
Publication of IL53323A publication Critical patent/IL53323A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL53323A 1976-11-12 1977-11-07 1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them IL53323A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
IL53323A0 IL53323A0 (en) 1978-01-31
IL53323A true IL53323A (en) 1981-12-31

Family

ID=25771134

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53323A IL53323A (en) 1976-11-12 1977-11-07 1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US4146630A (fi)
JP (1) JPS5363385A (fi)
AR (3) AR218643A1 (fi)
AT (1) AT361476B (fi)
AU (1) AU510284B2 (fi)
CA (1) CA1086740A (fi)
CH (3) CH636099A5 (fi)
CS (1) CS228106B2 (fi)
DD (1) DD133801A5 (fi)
DK (1) DK500677A (fi)
ES (2) ES472747A1 (fi)
FI (1) FI62077C (fi)
FR (1) FR2370744A1 (fi)
GB (1) GB1541547A (fi)
HU (1) HU177410B (fi)
IL (1) IL53323A (fi)
IT (1) IT1087490B (fi)
LU (1) LU78498A1 (fi)
NL (1) NL7712220A (fi)
PL (2) PL110782B1 (fi)
SE (1) SE7712720L (fi)
SU (2) SU826955A3 (fi)
YU (3) YU266477A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5741789A (en) * 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor
US8642583B2 (en) * 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS48103590A (fi) * 1972-04-13 1973-12-25
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
SU890975A3 (ru) 1981-12-15
CS228106B2 (en) 1984-05-14
JPS5363385A (en) 1978-06-06
YU128883A (en) 1984-04-30
NL7712220A (nl) 1978-05-17
US4146630A (en) 1979-03-27
PL110782B1 (en) 1980-07-31
ES472746A1 (es) 1979-02-16
CH636099A5 (de) 1983-05-13
CA1086740A (en) 1980-09-30
DK500677A (da) 1978-05-13
PL112683B1 (en) 1980-10-31
FR2370744A1 (fr) 1978-06-09
AU3046677A (en) 1979-05-17
SE7712720L (sv) 1978-05-12
IT1087490B (it) 1985-06-04
SU826955A3 (ru) 1981-04-30
FI62077B (fi) 1982-07-30
FR2370744B1 (fi) 1981-06-12
PL201997A1 (pl) 1979-03-12
CH643554A5 (de) 1984-06-15
CH639086A5 (de) 1983-10-31
ATA808277A (de) 1980-08-15
YU128983A (en) 1984-04-30
DD133801A5 (de) 1979-01-24
AR218643A1 (es) 1980-06-30
GB1541547A (en) 1979-03-07
AR221868A1 (es) 1981-03-31
FI62077C (fi) 1982-11-10
AT361476B (de) 1981-03-10
IL53323A0 (en) 1978-01-31
FI773346A (fi) 1978-05-13
YU266477A (en) 1984-02-29
AR221081A1 (es) 1980-12-30
HU177410B (en) 1981-10-28
LU78498A1 (fi) 1979-02-02
AU510284B2 (en) 1980-06-19
ES472747A1 (es) 1979-02-16
JPS6341910B2 (fi) 1988-08-19

Similar Documents

Publication Publication Date Title
DE2962051D1 (en) Benzimidazoles, their preparation and pharmaceutical compositions containing them
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL53323A (en) 1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them
IL61375A0 (en) Chloro and alkoxy-substituted-2,4-diaminoquinazolines and pharmaceutical compositions containing them
IL54842A0 (en) Novel phthalazine derivatives, their preparation and pharmaceutical compositions containing them
IL63968A0 (en) Aminoalkylfuran derivative,its preparation and pharmaceutical compositions containing it
IL62200A (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL55773A (en) Substituted 1-phenyl-4,4-dimethyl-imidazolyl(2,5-diones)or(2-one-5-imines),their preparation and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
IL62631A (en) Antiallergic bis(isoquinolyl)bis-sulfonylamines,their preparation and pharmaceutical compositions containing them
PH13607A (en) Antimalarial composition containing floxacrine
IL56076A (en) 2 alpha-cyano-4 alpha,5 alpha-epoxyandrostanes,their preparation and pharmaceutical compositions containing them
IL63423A0 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them
GB2074445B (en) Oral pharmaceutical compositions containing cytidine diphospholine
HK39881A (en) 4,9-dihydro-4,9-dioxo-1h-naphtho(2,3-d)triazoles,their preparation and antialiergic compositions containing them
DE3169095D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL53078A (en) Pharmaceutical compositions containing 2-phenylthio (sulfinyl)-4-alkylphenol derivatives,certain novel such compounds and their preparation
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
IL62320A (en) 1-(4-aryl-cyclohexyl)piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL54755A0 (en) Novel 5-aryl-hexahydro-pyrido(4,3-b)-indole derivatives and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
IL64555A0 (en) Pharmaceutical compositions containing 3-amine-2-pyrazoline derivatives,certain such novel derivatives and their preparation
IL55116A0 (en) Novel indole derivatives,their preparation and pharmaceutical compositions containing them
IL63245A (en) 3-aminopropoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them